Release 5.9.0: Saved Query Alerts, Query Details, Collection Sizes and more!

Saved Query Alerts.

Receive a notification email when new data is added for your saved queries.

Query Details Improvements.

View details of your joined query when navigating between cited/citing panes.

Collection Limit Increase.

Create collections of up to 50,000 Patents or Scholarly Works.

Pharmaceutical Composition For The Treatment Of Kidney Or Liver Fibrosis

Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

The present invention relates to the use of an antibody that specifically binds to integrin alpha ny beta 6 and blocks binding of a ligand to integrin alpha ny beta 6 for the preparation of a medicament intended for treating kidney or liver fibrosis in a patient wherein the antibody is a monoclonal antibody and wherein the antibody is intended for therapeutic or prophylactic administration. There are also disclosed monoclonal antibodies produced by a hybridoma ATCC HB12382 and the hybridoma ATCC HB12382 per se.


Claims

Information currently unavailable.

IPC Classifications
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Nov 19, 2008
  • Application: Aug 7, 1998
    CZ CZ 20000413 A
  • Priority: Aug 8, 1997
    US US 5506097 P

Sign in to the Lens